FOLH1 and neoplasm: Specifically, a pTLA ≥ 25.1 on PSMA-PET at initial staging was an independent factor for PSA persistence in multivariate analysis, suggesting that high tumor burden in the prostate gland before surgery could serve as an additional risk factor.